Correlation between histomorphometric parameters of bone resorption and serum type 5b tartrate-resistant acid phosphatase in uremic patients on maintenance hemodialysis

American Journal of Kidney Diseases

Volumn 41, Issue 5, 2003, Pages 1052-1059

  Chu, Pauling ^a   Chao, Tsu Yi ^b   Lin, Yuh Feng ^b   Janckila, Anthony J ^b   Yam, Lung T ^b  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

Bone histomorphometry; Bone resorption; Osteoclast; Renal osteodystrophy (ROD); Tartrate resistant acid phosphatase (TRACP)

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALBUMIN; BIOCHEMICAL MARKER; CALCIUM; COLLAGEN TYPE 1; PARATHYROID HORMONE; PHOSPHORUS; PYRIDINOLINE;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BONE BIOPSY; CALCIUM BLOOD LEVEL; CELL ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; MALE; MORPHOMETRICS; OSTEOCLAST; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PROTEIN CROSS LINKING; RENAL OSTEODYSTROPHY; UREMIA;

ACID PHOSPHATASE; BONE AND BONES; BONE RESORPTION; FEMALE; HUMANS; ISOENZYMES; OSTEOMALACIA; RENAL DIALYSIS; RENAL OSTEODYSTROPHY; UREMIA;

EID: 0038417857     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(03)00203-8     Document Type: Article

References (27)

1. Sherrard DJ, Hercz G, Pei Y, et al: The spectrum of bone disease in end-stage renal failure: An evolving disorder. Kidney Int 43:436-442, 1993
2. Malluche HH, Faugere MC: Renal bone disease 1990: An unmet challenge for the nephrologist. Kidney Int 38:193-211, 1990
3. Delmez JA, Slatopolsky E: Clinical review 20: Recent advances in the pathogenesis and therapy of uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 72:735-739, 2001
4. Hruska KA, Teitelbaum SL: Renal osteodystrophy. N Engl J Med 333:166-174, 1995
5. Andress DL, Endres DB, Maloney NA, et al: Comparison of parathyroid hormone assays with bone histomorphometry in renal osteodystrophy. J Clin Endocrinol Metab 63:1163-1169, 1986
6. Fletcher S, Jones RG, Rayner HC, et al: Assessment of renal osteodystrophy in dialysis patients: Use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology. Nephron 75:412-419, 1997
7. Risteli J, Elomaa I, Niemi S, Novario A, Risteli L: Radioimmunoassay for the pyridinoline cross-linked carboxyterminal telopeptide of type I collagen: A new serum marker of bone collagen degradation. Clin Chem 39:635-640, 1993
8. Halleen JM, Alatalo SL, Suominen H, Cheng S, Janckila AJ, Väänänen HK: Tartrate-resistant acid phosphatase 5b: A novel serum marker of bone resorption. J Bone Miner Res 15:1337-1345, 2000
9. Halleen JM, Alatalo SL, Janckila AJ, Woitge HW, Seibel MJ, Väänänen HK: Serum tartrate-resistant acid phosphatase 5b is a specific and sensitive marker of bone resorption. Clin Chem 47:597-600, 2001
10. Janckila AJ, Takahashi K, Sun SZ, Yam LT: Tartrateresistant acid phosphatase isoform 5b as serum marker for osteoclastic activity. Clin Chem 47:74-80, 2001
11. Faugere M-C, Malluche HH: Stainable aluminum and not aluminum content reflects bone histology in dialyzed patients. Kidney Int 30:717-722, 1986
12. Nussbaum SR, Zahradnik RJ, Lavigne JR, et al: Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 33:1364-1367, 1988
13. Risteli J, Elomaa I, Niemi S, Novario A. Risteli L: Radioimmunoassay for the pyridinoline cross-linked carboxyterminal telopeptide of type I collagen: A new serum marker of bone collagen degradation. Clin Chem 39:635-640, 1993
14. de Vernejoul MC, Kuntz D, Miravet L, Gueris J, Bielakoff J, Ryckewaert A: Bone histomorphometry in hemodialyzed patients. Metab Bone Dis Relat Res 3:175-179, 1981
15. Parfitt AM, Drezner MK, Glorieux FH, et al: Bone histomorphometry. Standardization of nomenclature, symbols, and units. J Bone Miner Res 2:595-610, 1987
16. Sherrard DJ, Baylink DJ, Wergedal JE, Maloney N: Quantitative histological studies on the pathogenesis of uremic bone disease. J Clin Endocrinol Metab 39:119-135, 1974
17. Salusky IB, Ramirez JA, Oppenheim WL, Gales B, Segre GV, Goodman WG: Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD. Kidney Int 45:253-258, 1994
18. Pei Y, Hercz G, Greenwood C, et al: Non-invasive prediction of aluminum bone disease in hemo- and peritoneal dialysis patients. Kidney Int 41:1374-1382, 1992
19. Cohen-Solal M, Sebert JL, Boudailliez B, et al: Comparison of intact, midregion, and carboxyl terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialysis patients. J Clin Endocrinol Metab 73:516-524, 1991
20. Ureña P, Kubrusly M, Mannstadt M, et al: The renal PTH/PTHrP receptor is down-regulated in rats with chronic renal failure. Kidney Int 45:605-611, 1994
21. Urefia P, Hruby M, Ferreira A, Ang K, de Vernejoul M: Plasma total versus bone alkaline phosphatase as marker of bone turnover in hemodialysis patients. J Am Soc Nephrol 7:506-512, 1996
22. Stepan JJ, Silinkova-Malkova E, Havranek T, et al: Relationship of plasma tartrate resistant acid phosphatase to the bone isoenzyme of serum alkaline phosphatase in hyperparathyroidism. Clin Chim Acta 133:189-200, 1983
23. Lau KH-W, Onishi T, Wergedal JE, Singer FR, Baylink DJ: Characterization and assay of tartrate-resistant acid phosphatase activity in serum: Potential use to assess bone resorption. Clin Chem 33:458-462, 1987
24. Wada N, Fujusaki M, Ishii S, Ikeda T, Kitajima M: Evaluation of bone metabolic markers in breast cancer with bone metastasis. Breast Cancer 47:74-80, 2001
25. Takahashi K, Janckila AJ, Sun SZ, Lederer ED, Ray PC, Yam LT: Electrophoretic study of tartrate-resistant acid phosphatase isoforms in end-stage renal disease and rheumatoid arthritis. Clin Chim Acta 301:147-158, 2000
26. Canavese C, Barolo S, Gurioli L, et al: Correlations between bone histopathology and serum biochemistry in uremic patients on chronic hemodialysis. Int J Artif Organs 21:443-450, 1998
27. Coen G, Ballanti P, Bonucci E, et al: Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients. Nephrol Dial Transplant 13:2294-2302, 1998